Article

Orlistat-Induced Bullous Leukocytoclastic Vasculitis

Cutaneous leukocytoclastic vasculitis (LCV), also known as small-vessel vasculitis, is a process thought to be related to the presence of circulating immune complexes. Leukocytoclastic vasculitis is thought to be idiopathic in up to 50%of cases, but other common causes and associated disorders include certain medications, most frequently antibiotics; infections;collagen-vascular disease; paraproteinemias; and rarely neoplasia. We report a patient with cutaneous LCV induced by orlistat, a pancreatic lipase inhibitor that works as a weight-loss agent by decreasing the absorption of dietary fat.


 

Recommended Reading

Dermatitis Herpetiformis
MDedge Dermatology
Aquatic Antagonists: Bluegill (Lepomis macrochirus)
MDedge Dermatology
Angiosarcoma in a Patient With Congenital Nonhereditary Lymphedema
MDedge Dermatology
Phototoxic and Photoallergic Potential of Tazarotene Foam 0.1% in 2 Phase 1 Patch Studies
MDedge Dermatology
Woringer-Kolopp Disease Mimicking Foot Dermatitis
MDedge Dermatology
What Is Your Diagnosis? Radiation Recall Dermatitis
MDedge Dermatology
Small Vessel Vasculitis Associated With Cocaine Use
MDedge Dermatology
Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema
MDedge Dermatology
Heparin-Induced Bullous Hemorrhagic Dermatosis
MDedge Dermatology
Timing of Return Office Visit Affects Adherence to Topical Treatment in Patients With Atopic Dermatitis: An Analysis of 5 Studies
MDedge Dermatology